Crystalline domains are structural units within microcrystalline cellulose that determine its pharmaceutical-grade properties and functionality.
| Parameter | Typical range | Notes & selection driver |
|---|---|---|
| Domain Size | 10-50 nm | |
| Bulk Density | 0.25-0.45 g/cm³ | |
| Tapped Density | 0.35-0.55 g/cm³ | |
| Moisture Content | ≤5.0% | |
| Crystallinity Index | 60-85% | |
| PH (10% Suspension) | 5.0-7.5 | |
| Particle Size Distribution | D50: 50-150 μm |
Ranges are indicative industry figures for RFQ preparation, not a supplier commitment. Confirm every value and standard with the legal manufacturer before ordering.
This component is used in the following industrial products
A practical evidence checklist for RFQ preparation and supplier evaluation.
Compare the published product scope and source details, then include your specifications and quantity in an enquiry.
Manufacturer profiles associated with Crystalline Domains.
Explore company information and manufacturing capabilities, then discuss the scope of your project with a relevant supplier.
Crystalline domains provide the structural framework that enables microcrystalline cellulose to function as an effective binder and disintegrant in tablet formulations, ensuring consistent compression behavior and predictable drug release profiles.
Optimal crystalline domain structure creates a balance between tablet hardness (through effective bonding during compression) and rapid disintegration (through capillary action and swelling), ensuring both mechanical strength and efficient drug release.
Editorial classification, named public sources where available, and source-reviewed manufacturer records. See the editorial policy.